Home›Research›Compare›Ac-SDKP vs Teduglutide
Peptide ComparisonAc-SDKP vs Teduglutide
Both are Tissue Repair peptides.
Ac-SDKP
N-acetyl-seryl-aspartyl-lysyl-proline
No providers listed yet
Teduglutide
Gattex
Half-life: ~2 hours
No providers listed yet
Teduglutide is FDA-approved, while Ac-SDKP is not evaluated — the clearest structural difference between them.
Ac-SDKP
Evidence
Half-life
—
Teduglutide
Evidence
Half-life
~2 hours
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Teduglutide |
| Further along in FDA review | Teduglutide |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Ac-SDKP
Teduglutide
Ac-SDKP
Device surface-functionalized ac-SDKP nanoassemblies accelerate endothelial recovery through dual anti-inflam…
Ac-SDKP Attenuates Silica-Induced Pulmonary Fibrosis by Inhibiting ALKBH1-Mediated m(6)A Demethylation of miR…
N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythe…
Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis
Teduglutide
From childhood to adulthood in chronic intestinal failure: A nationwide study.
A Long-Acting Glucagon-like Peptide 2 Protracted by Coomassie Brilliant Blue to Enhance Intestinal Growth in…
PERCC1-associated enteropathy: Diagnostic challenges and enteral autonomy achieved with teduglutide.
Glucagon-like peptide agonists and use in short bowel syndrome - what about the side effects?
+5 more
About Ac-SDKP
Inhibits hematopoietic stem cell entry into S-phase. Blocks TGF-β1-mediated fibroblast activation, reducing collagen deposition. Promotes angiogenesis via VEGF upregulation. Regulated in vivo by ACE enzyme.
About Teduglutide
GLP-2 receptor agonist; stimulates intestinal epithelial proliferation and reduces apoptosis; increases intestinal blood flow and inhibits gastric motility
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Ac-SDKP
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Teduglutide
No established clinical contraindications
Under clinical review
Being verified by our medical team before we display monitoring guidance for this peptide.
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Tissue Repair Comparisons
Browse all peptides →Educational research tools — not medical advice.